C31H32N10O3S — CID 88561511
3-[(2R)-1-[1-(4-amino-1,2,5-oxadiazol-3-yl)-5-phenyltriazole-4-carbonyl]pyrrolidin-2-yl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide (PubChem CID 88561511) has the molecular formula C31H32N10O3S and a molecular weight of 624.73 g/mol. Its IUPAC name is 3-[(2R)-1-[1-(4-amino-1,2,5-oxadiazol-3-yl)-5-phenyltriazole-4-carbonyl]pyrrolidin-2-yl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide.
| Compound Name | 3-[(2R)-1-[1-(4-amino-1,2,5-oxadiazol-3-yl)-5-phenyltriazole-4-carbonyl]pyrrolidin-2-yl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide |
|---|---|
| PubChem CID | 88561511 |
| Molecular Formula | C31H32N10O3S |
| Molecular Weight | 624.73 g/mol |
| Exact Mass | 624.24 |
| IUPAC Name | 3-[(2R)-1-[1-(4-amino-1,2,5-oxadiazol-3-yl)-5-phenyltriazole-4-carbonyl]pyrrolidin-2-yl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide |
| SMILES | CN(C)[C@H]1CCc2nc(NC(=O)c3cccc([C@H]4CCCN4C(=O)c4nnn(-c5nonc5N)c4-c4ccccc4)c3)sc2C1 |
| InChI | InChI=1S/C31H32N10O3S/c1-39(2)21-13-14-22-24(17-21)45-31(33-22)34-29(42)20-11-6-10-19(16-20)23-12-7-15-40(23)30(43)25-26(18-8-4-3-5-9-18)41(38-35-25)28-27(32)36-44-37-28/h3-6,8-11,16,21,23H,7,12-15,17H2,1-2H3,(H2,32,36)(H,33,34,42)/t21-,23+/m0/s1 |
| InChIKey | OOUVFKZYPAUJPH-JTHBVZDNSA-N |
| XLogP | 4.00 |
| TPSA | 161.19 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 45 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 624.73 |
| LogP ≤ 5 | 4.00 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 12 |